Antibody avidity fulfills multiple myeloma In the ongoing try to find ground breaking therapies to combat refractory and relapsed most cancers, new preclinical perform in several myeloma shows that increasing binding avidity by concentrating on two antigens in one T cell-participating trispecific antibody boosts anti-tumor exercise and lowers the l